Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data

INTRODUCTION: An extensive clinical development program showed that the meningococcal serogroup B-factor H binding protein (MenB-FHbp) vaccine affords protection against MenB disease for adolescents and adults. Data were pooled from multiple studies within the program to examine whether MenB-FHbp im...

Descripción completa

Detalles Bibliográficos
Autores principales: Beeslaar, Johannes, Peyrani, Paula, Absalon, Judith, Maguire, Jason, Eiden, Joseph, Balmer, Paul, Maansson, Roger, Perez, John L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452992/
https://www.ncbi.nlm.nih.gov/pubmed/32681472
http://dx.doi.org/10.1007/s40121-020-00322-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452992/
https://www.ncbi.nlm.nih.gov/pubmed/32681472
http://dx.doi.org/10.1007/s40121-020-00322-5

Ejemplares similares